Rick Doblin
Rick Doblin is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), which has become one of the leading organizations behind modern psychedelic research. A pioneering activist, he received his doctorate in Public Policy from Harvard’s Kennedy School of Government and has dedicated his life to legalizing psychedelics. With his colleagues at MAPS, Doblin spearheaded the world’s first ever Phase III clinical trial investigating psychedelics, which produced extremely promising results for PTSD patients using MDMA-assisted psychotherapy.